Dr. Thomas Aghahowa Imahiyerobo Jr., MD

Dr. Imahiyerobo practices at Trustees of Columbia University in the City of New York in Fort Lee, New Jersey.

Dr. Imahiyerobo's NPI, 1144473117, was assigned on November 3, 2008. Dr. Imahiyerobo graduated from Harvard Medical School in 2008. Dr. Imahiyerobo holds New York license 267233.

Dr. Imahiyerobo's primary practice is Trustees of Columbia University in the City of New York, at 400 Kelby St, Fort Lee, NJ 07024 in Bergen County. The practice phone is (646) 317-7111.

Dr. Imahiyerobo's primary practice is Trustees of Columbia University in the City of New York in Fort Lee, New Jersey. Dr. Imahiyerobo is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Imahiyerobo to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Imahiyerobo practices, 4 sites in all. Vendor and product names are available with a free account.

Plastic and reconstructive surgery is Dr. Imahiyerobo's primary specialty in the NPI Registry, under taxonomy code 2086S0122X. Dr. Imahiyerobo is board certified in plastic surgery by the American Board of Plastic Surgery. Dmand AI has Dr. Imahiyerobo's licenses on file in 3 states: New York, California and New Jersey.

Dmand AI lists head wound and removal of damaged skin or skin graft among the conditions Dr. Imahiyerobo treats.

CMS data shows 22 Medicare services from Dr. Imahiyerobo across 1 procedure code in 2019, all of them office visits, for 14 Medicare patients. Medicare paid $790 for them. Every service was in an office.

CMS counts 14 Medicare patients who saw Dr. Imahiyerobo in 2024. The largest group is 85 and over, with 0 patients. 75% of them have high blood pressure. Their average risk score is 2.34, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Imahiyerobo's median patient age at 11, with 47% women.

In 2016, Dr. Imahiyerobo wrote 13 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $106 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Imahiyerobo for performance year 2024, reported through an alternative payment model (APM). Dr. Imahiyerobo accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 37 papers to Dr. Imahiyerobo, published from 2013 to 2025. 2022 was the busiest year, with 3. The most frequent topics are Craniosynostoses, Plastic Surgery Procedures and Postoperative Complications. Dr. Imahiyerobo has published most often in J Craniofac Surg. Dr. Imahiyerobo's most frequent co-authors are Caitlin E. Hoffman, MD, Mark M. Souweidane, MD and Alyssa Valenti.

CMS Open Payments shows 115 general payments to Dr. Imahiyerobo from 25 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 47% of the total. Integra LifeSciences Corporation paid the most, $13,768.

Dr. Imahiyerobo graduated from Harvard Medical School in 2008.

Dr. Imahiyerobo is in network with 18 carriers, including Aetna, Elevance and United Healthcare. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.